Search company, investor...

Ocean Ridge Biosciences

oceanridgebio.com

Founded Year

2006

Stage

Acquired | Acquired

About Ocean Ridge Biosciences

Ocean Ridge Biosciences provides biotechnology research tools. It provides genomic services to the health care and life science industries. It is based in Deerfield Beach, Florida.On April 21, 2021, Ocean Ridge Biosciences was acquired by Frontage Laboratories. The terms of the transaction were not disclosed.

Headquarters Location

394 SW 12th Avenue Building #6

Deerfield Beach, Florida, 33442,

United States

Missing: Ocean Ridge Biosciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Ocean Ridge Biosciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Ocean Ridge Biosciences News

Healthcare Analytical Testing Services Market Value Predicted To Reach US$ 20.7 Billion By 2027 Covering Pre and Post COVID-19 Market Analysis: Acumen Research and Consulting

Apr 28, 2021

Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Healthcare analytical testing services Market– Global Industry Analysis, Market Size, Opportunities and Forecast, 2020-2027” April 28, 2021 11:30 ET Pune, INDIA LOS ANGELES, April 28, 2021 (GLOBE NEWSWIRE) -- The Global Healthcare Analytical Testing Services Market is expected to grow at a CAGR of around 9.4% from 2020 to 2027 and reach the market value of over US$ 20.7 Bn by 2027. Analytical testing services are the techniques that are used to identify a variety of characteristics and chemical makeup of a particular sample. The advancements in healthcare analytical testing for quantitation of elemental impurities in prescription and non-prescription human drug products are rising, specifically using plasma spectrometry, ICP-MS or ICP-OES, to screen and/or accurately quantitate the presence of any elemental impurities of interest. The global healthcare analytical testing services market is segmented on the basis of type, end-user, and geography. On the basis of type, the market is bifurcated across bioanalytical testing services, physical characterization services, method development & validation services, raw material testing services, batch-release testing services, stability testing, microbial testing services, and environmental monitoring services. Additionally, the end-user segment of the market is studied across pharmaceutical & biopharmaceutical companies, contract research organizations, and medical device companies. DOWNLOAD SAMPLE PAGES OF THIS REPORT@ https://www.acumenresearchandconsulting.com/request-sample/2594 Based on the end-user, pharmaceutical & biopharmaceutical companies segment is leading the market with maximum revenue share (%) in terms of revenue. The increasing investment in analytical services by the pharmaceutical & biopharmaceutical companies is additionally supporting the regional market value. The strategic developments by the companies in order to expand their share in the foreign market as well as to develop and increase usage of more reliable drugs is further boosting the segmental market value. Covid-19 impact on the market The coronavirus has disrupted global operations due to nationwide lockdowns. Whereas, the analytics testing service segment has gain growth due to increasing testing services for the development of coronavirus medication. North America held the maximum revenue share in the global healthcare analytical testing services market and the region is also projected to maintain its dominance over the forecast period from 2020 to 2027. The major economies of the region including the US and Canada are the major revenue contributors. The presence of major players in the region coupled with their continuous efforts for the development of advanced research methodologies for the development of advanced solutions is additionally contributing to the regional market value. VIEW TABLE OF CONTENT OF THIS REPORT@ https://www.acumenresearchandconsulting.com/healthcare-analytical-testing-services-market Asia Pacific along with its emerging economies projected to exhibit the fastest growth during the forecast period from 2020 to 2027. The developing healthcare infrastructure and rising focus of major manufacturers in the regional market due to the availability of abundant opportunities in near future are further bolstering the regional market value. Some of the leading competitors are Charles River Laboratories International, Inc., Eurofins Scientific, ICON plc, Intertek Group, LabCorp, Pace Analytical Services, LLC, PPD, Inc., SGS SA, Syneos Health, and Toxikon, Inc. The major players are involved in strategic developments like mergers & acquisitions, new product launch, and partnerships & collaborations. Browse Upcoming Market Research Reports@  https://www.acumenresearchandconsulting.com/forthcoming-reports Some of the key observations regarding the healthcare analytical testing services industry include: In 2020, Emergent BioSolutions signed a CDMO agreement with AstraZeneca’s vaccine candidate for COVID-19. Under the agreement, Emergent BioSolutions is likely to provide analytical testing services to AstraZeneca. This strategic collaboration is intended to provide growth to both organizations. Alcami Corporation offers value-added risk assessment screenings using scientifically sound methods for the analysis of excipients, APIs, and drug products as well. Frontage Laboratories, Inc. has acquired Ocean Ridge Biosciences in 2021. With this acquisition, the company has expanded its Genomics Services section. Moreover, the comprehensive services of Frontage include drug metabolism and pharmacokinetics, analytical testing and formulation development, bioanalysis, preclinical and clinical trial material manufacturing, preclinical safety and toxicology assessment, and early phase clinical studies. In 2021, LumaCyte, a leader in advanced label-free single-cell analytics has announced the addition of Jim Robinson to its Scientific Advisory Board (SAB). The company's CEO and CSO said that they offer a highly advanced analytics platform that provides real-time viral infectivity monitoring along with the unique ability to improve vaccine production coupled with the extend product shelf life through precise viral titer and accurate measurements. INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/2594 BUY THIS PREMIUM RESEARCH REPORT - https://www.acumenresearchandconsulting.com/buy-now/0/2594 Would like to place an order or any question, please feel free to contact at  sales@acumenresearchandconsulting.com  | +1 407 915 4157 For Latest Update Follow Us:

Ocean Ridge Biosciences Frequently Asked Questions (FAQ)

  • When was Ocean Ridge Biosciences founded?

    Ocean Ridge Biosciences was founded in 2006.

  • Where is Ocean Ridge Biosciences's headquarters?

    Ocean Ridge Biosciences's headquarters is located at 394 SW 12th Avenue, Deerfield Beach.

  • What is Ocean Ridge Biosciences's latest funding round?

    Ocean Ridge Biosciences's latest funding round is Acquired.

  • Who are the investors of Ocean Ridge Biosciences?

    Investors of Ocean Ridge Biosciences include Frontage Laboratories.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.